Integrative Predictive Modeling in Complex Pathology: Bridging Genetic Architectures, Clinical Biomarkers, and Statistical Nomograms for Multimodal Risk Stratification

Abstract

Background: The stratification of patient risk in complex diseases—ranging from neurodegenerative disorders like Alzheimer’s Disease to vascular pathologies like Abdominal Aortic Aneurysm (AAA)—remains a significant challenge due to the heterogeneity of biological drivers. Traditional single-biomarker approaches often fail to capture the systemic nature of these conditions.

Methods: This study synthesizes a multimodal methodological framework, integrating insights from Genome-Wide Association Studies (GWAS) regarding shared genetic loci in Schizophrenia and Alzheimer’s, with clinical proteomic data and routine biomarkers such as Blood Urea Nitrogen (BUN). We further analyze the statistical application of regularized Cox regression and the construction of prognostic nomograms to translate these multidimensional data into clinically usable tools.

Results: Genetic analysis confirms significant overlap in risk loci between psychiatric and neurodegenerative traits, suggesting shared inflammatory pathways. Clinically, elevated BUN is identified as an independent predictor of mortality in AAA and sepsis, distinct from creatinine. The application of decision curve analysis (DCA) and time-dependent ROC curves demonstrates that nomogram-based models significantly outperform standard staging systems in predicting overall survival and disease-free survival.

Conclusion: Effective risk prediction requires a transition from isolated marker identification to integrative modeling. By combining genetic susceptibility scores with dynamic clinical biomarkers through rigorous statistical nomograms, clinicians can achieve higher predictive accuracy and personalized patient management.

Keywords:

Predictive Modeling, Genome-Wide Association Studies, Abdominal Aortic Aneurysm, Schizophrenia, Nomograms, Blood Urea Nitrogen, Decision Curve Analysis

References

Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511: 421-7.

Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization. JAMA. 2017; 318: 1925-6.

Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nature genetics. 2016; 48: 481-7.

Geerts H. alpha7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer’s disease. Expert opinion on investigational drugs. 2012; 21: 59-65.

Kochunov P, Zavaliangos-Petropulu A, Jahanshad N, Thompson PM, Ryan MC, Chiappelli J, et al. A White Matter Connection of Schizophrenia and Alzheimer’s Disease. Schizophr Bull. 2021; 47: 197-206.

Padyukov L. Genetics of rheumatoid arthritis. Semin Immunopathol. 2022; 44: 47-62.

Benros ME, Pedersen MG, Rasmussen H, Eaton WW, Nordentoft M, Mortensen PB. A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am J Psychiatry. 2014; 171: 218-26.

Sellgren C, Frisell T, Lichtenstein P, Landen M, Askling J. The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks. Schizophr Bull. 2014; 40: 1552-9.

Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nature genetics. 2021; 53: 392-402.

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nature genetics. 2019; 51: 414-30.

Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nature genetics. 2021; 53: 1712-21.

Walker KA, Chen J, Shi L, Yang Y, Fornage M, Zhou L, et al. Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Science translational medicine. 2023; 15: eadf5681.

Yang C, Fagan AM, Perrin RJ, Rhinn H, Harari O, Cruchaga C. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes. Genome Med. 2022; 14: 140.

Simon N, Friedman J, Hastie T, Tibshirani R. Regularization Paths for Cox’s Proportional Hazards Model via Coordinate Descent. J Stat Soft. 2011;39(5). doi:10.18637/jss.v039.i05

Zhang Z, Kattan MW. Drawing Nomograms with R: applications to categorical outcome and survival data. Ann Transl Med. 2017;5(10):211-211. doi:10.21037/atm.2017.04.01

Shen L, Jiang Y, Zhang T, et al. Machine Learning for Dynamic Prognostication of Patients With Hepatocellular Carcinoma Using Time-Series Data: Survival Path Versus Dynamic-DeepHit HCC Model. Cancer Inform. 2024;23:11769351241289719. doi:10.1177/11769351241289719

Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17(1):53. doi:10.1186/s12874-017-0332-6

Huang Y, Li W, Macheret F, Gabriel RA, Ohno-Machado L. A tutorial on calibration measurements and calibration models for clinical prediction models. Journal of the American Medical Informatics Association. 2020;27(4):621-633. doi:10.1093/jamia/ocz228

Zhao L, Leng Y, Hu Y, et al. Understanding decision curve analysis in clinical prediction model research. Postgraduate Medical Journal. 2024;100(1185):512-515. doi:10.1093/postmj/qgae027

Harazim M, Tan K, Nalos M, Matejovic M. Blood urea nitrogen - independent marker of mortality in sepsis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023;167(1):24-29. doi:10.5507/bp.2022.015

Xue K, Xing S. Blood urea nitrogen concentration is associated with severe abdominal aortic calcification in adults: a cross-sectional investigation. Sci Rep. 2023;13(1):19834. doi:10.1038/s41598-023-47109-5

Tian K, Thanigaimani S, Gibson K, Golledge J. Systematic Review Examining the Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Prescription and Abdominal Aortic Aneurysm Growth and Events. European Journal of Vascular and Endovascular Surgery. 2024;68(2):180-187. doi:10.1016/j.ejvs.2024.03.034

Elsayed N, Gaffey AC, Abou‐Zamzam A, Malas MB. Renin‐Angiotensin‐Aldosterone System Inhibitors Are Associated With Favorable Outcomes Compared to Beta Blockers in Reducing Mortality Following Abdominal Aneurysm Repair. JAHA. 2023;12(14):e029761. doi:10.1161/JAHA.122.029761